Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

PubMed

PCSK9 inhibitors slightly increase the risk of severe injection-site reaction but not cataracts, gastrointestinal haemorrhage, neurocognitive events, new-onset diabetes or severe myalgia or muscular pain.

  • 123456 Profile photo of Madelyn

    Safety of cholesterol lowering injections